David Poon: Excited to introduce DCx Biotherapeutics Corporation – a new adventure I have co-founded
David Poon
“Extremely excited to introduce DCx Biotherapeutics Corporation, a new adventure I have co-founded with my close and trusted colleagues (Ali Tehrani and Candice Madalena), supported by Amplitude Ventures, to rethink the development of 1st-in-class precision drug conjugates that are more efficacious and better tolerated than traditional antimitotic or topoisomerase inhibiting ADCs.
Please DM me to chat about collaboration opportunities (novel payloads, targets, & targeting modalities) or if you are interested to join our journey to make a difference for patients.”
Source: David Poon/LinkedIn
David Poon is the Co-Founder of DCx Biotherapeutics Corporation. He is also the Business Development, Strategy, and Transactions Advisor at SynapticBio Strategic Advisors Inc. and Director of Life Sciences BC. He is a board member of BioCanRx.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023